NSEShareholders meeting30 Jun 2026 · 30 Jun 2026, 07:32 pm
Shareholders meeting
Dr. Reddy's Laboratories Limited · DRREDDY
✦ AI SummaryMgmt Change
Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of 42nd Annual General Meeting to be held on July 23, 2026, to consider and pass various resolutions including re-appointment of a director, appointment of statutory auditors, and declaration of final dividend.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of 42nd Annual General Meeting to be held on July 23, 2026
Attachments (1)
📄pdf
Download →
DRREDDY_30062026193148_AGM_Notice_sigend.pdf
View document text
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
June 30, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/ Madam,
Sub: Notice of 42nd Annual General Meeting
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, please find enclosed a copy of Notice convening the 42nd Annual
General Meeting (“AGM”) of the Company, scheduled to be held on Thursday, July 23, 2026 at 11:00
A.M. IST through Video Conferencing/ Other Audio-Visual Means. The Notice of AGM is also
available on the Company’s website and can be accessed at the following link:
Notice of 42nd Annual General Meeting
Please also refer below AGM related information:
Time and date of AGM 11:00 a.m. IST, Thursday, July 23, 2026
Cut-off date Thursday, July 16, 2026
E-voting start time and date 9.00 a.m. IST, Sunday, July 19, 2026
E-voting end time and date 5.00 p.m. IST, Wednesday, July 22, 2026
E-voting website of NSDL https://www.evoting.nsdl.com/
Helpline number for VC +91-22-4886 7000 and +91-22-2499 7000
participation
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer and Head-CSR
NOTICE OF 42ND ANNUAL GENERAL MEETING
Regd. Office: 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034
CIN: L85195TG1984PLC004507, Tel: 91 40 4900 2900, Fax: 91 40 4900 2999
Email: shares@drreddys.com, Website: www.drreddys.com
Notice is hereby given that the 42nd Annual General Meeting 3. To re-appoint Mr. K Satish Reddy (DIN: 00129701), as
(“AGM”) of the members of Dr. Reddy’s Laboratories a Director, who retires by rotation and being eligible,
Limited (“Company”) will be held on Thursday, July 23, has offered himself for re-appointment.
2026, at 11.00 a.m. (“IST”) through Video Conferencing
To consider and, if thought fit, to pass, the following
(“VC”)/ Other Audio-Visual Means (“OAVM”), to transact the
resolution as an Ordinary Resolution:
following businesses:
“RESOLVED THAT pursuant to the applicable
ORDINARY BUSINESS:
provision(s) of the applicable law(s) (including any
1. To receive, consider and adopt the Audited Financial amendments thereto or re-enactment thereof for the
Statements (Standalone and Consolidated) of the time being in force), in accordance with the Articles of
Company for the financial year ended March 31,
Association of the Company and upon recommendation
2026, together with the Reports of the Board of
of the Nomination, Governance and Compensation
Directors and Auditors thereon.
Committee and the Board of Directors, Mr. K Satish
To consider and, if thought fit, to pass, the following Reddy (DIN: 00129701), Director, who retires by
resolution as an Ordinary Resolution: rotation and being eligible, has offered himself for
re-appointment, be and is hereby re-appointed as a
“RESOLVED THAT the audited standalone financial Director of the Company, liable to retire by rotation.”
statements of the Company for the financial year ended
March 31, 2026 together with the reports of the Board 4. To appoint M/s. Deloitte Haskins & Sells, LLP,
of Directors and Auditors thereon, as circulated to the Chartered Accountants as Statutory Auditors for
members, be and are hereby approved and adopted. a period of five consecutive years and fix their
remuneration.
RESOLVED FURTHER THAT the audited consolidated To consider and, if thought fit, to pass, the following
financial statements of the Company for the financial resolution as an Ordinary Resolution:
year ended March 31, 2026 together with the report of
the Auditors thereon, as circulated to the members, be “RESOLVED THAT pursuant to the provisions of
and are hereby approved and adopted.” Sections 139, 142 and other applicable provisions, if any,
of the Companies Act, 2013 read with the Companies
2. To declare a final dividend of ` 8/- per equity share
(Audit and Auditors) Rules, 2014, (including any statutory
of the face value of ` 1/- each, for the financial year
modification(s) or re-enactment thereof, for the time
ended March 31, 2026.
being in force) and based on the recommendations
To consider and, if thought fit, to pass, the following of the Audit Committee and the Board of Directors,
resolution as an Ordinary Resolution: M/s. Deloitte Haskins & Sells, LLP, Chartered
Accountants (Firm Registration No.117366W/W-100018),
“RESOLVED THAT approval be and is hereby accorded be and is hereby appointed as statutory auditors of
for declaration and payment of final dividend of ₹ 8 the Company, in place of retiring auditors M/s. S. R.
(Rupee Eight) per equity share of the face value of ₹ Batliboi & Associates LLP, Chartered Accountants (Firm
1 (Rupee One) each fully paid up, of the Company, as Registration No. 101049W/E300004), to hold office for
recommended by the Board of Directors of the Company the period of five consecutive years commencing from
for the financial year ended March 31, 2026." the conclusion of this 42nd Annual General Meeting until
the conclusion of the 47th Annual General Meeting, at RESOLVED FURTHER THAT the Board of Directors
such remuneration and reimbursement of out of pocket of the Company be and is hereby authorised to do and
expenses based on the recommendation of the Audit perform all such acts, deeds, matters and things, as may
Committee, as may be determined by the Board of be considered necessary, desirable or expedient to give
Directors of the Company. effect to this resolution.”
RESOLVED FURTHER THAT the Board of Directors of 6. To appoint Mr. Srikanth Velamakanni (DIN: 01722758)
as an independent director of the Company.
the Company or any duly constituted Committee of the
Board, be and is hereby authorized to do all such acts, To consider, and if thought fit, to pass, the following
deeds, matters and things as may be necessary, proper resolution as a Special Resolution:
or expedient to give effect to this resolution.”
“RESOLVED THAT pursuant to the provisions of
SPECIAL BUSINESS Sections 149, 150, 152, 161, and other applicable
provisions of the Companies Act, 2013 (“the Act”),
5. To re-appoint Dr. K P Krishnan (DIN: 01099097), as
read with Schedule IV of the Act and the rules made
an Independent Director for a second term of five
consecutive years. thereunder, and the applicable provisions of the SEBI
(Listing Obligations and Disclosure Requirements)
To consider and, if thought fit, to pass, the following
Regulations, 2015 (“SEBI Listing Regulations”) (including
resolution as a Special Resolution:
any statutory modification(s) or re-enactment(s) thereof
for the time being in force), and in accordance with the
“RESOLVED THAT pursuant to the provisions of
Articles of Association of the Company, and based on
Sections 149, 152 and other applicable provisions of
the recommendation of the Nomination, Governance and
the Companies Act, 2013, (“Act”) read with Schedule
Compensation Committee and the Board of Directors,
IV of the Act and the Rules made thereunder, the
Mr. Srikanth Velamakanni, (DIN: 01722758), who was
applicable provisions of the SEBI (Listing Obligations
appointed as an Additional Director in the category of an
and Disclosure Requirements) Regulations, 2015
Independent Director with effect from July 1, 2026, who
(“SEBI Listing Regulations”) (including any statutory
meets the criteria of independence as prescribed under
modification(s) or re-enactment(s) thereof for the time Section 149(6) of the Act and Regulation 16(1)(b) of the
being in force), and in accordance with the Articles SEBI Listing Regulations, and in respect of whom the
of Association of the Company, and based on the Company has received a notice in writin
[Showing first 8,000 characters — download PDF for full document]